These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 9846573
1. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hussain SP, Tzeng EE, Geller DA, Billiar TR, Harris CC. Nat Med; 1998 Dec; 4(12):1371-6. PubMed ID: 9846573 [Abstract] [Full Text] [Related]
2. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC. Cancer Res; 1998 Jan 15; 58(2):334-41. PubMed ID: 9443414 [Abstract] [Full Text] [Related]
3. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production. Konopka TE, Barker JE, Bamford TL, Guida E, Anderson RL, Stewart AG. Cancer Res; 2001 Apr 01; 61(7):3182-7. PubMed ID: 11306506 [Abstract] [Full Text] [Related]
4. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Welsh SJ, Bellamy WT, Briehl MM, Powis G. Cancer Res; 2002 Sep 01; 62(17):5089-95. PubMed ID: 12208766 [Abstract] [Full Text] [Related]
5. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MP, Presta M. Am J Pathol; 2003 Jun 01; 162(6):1913-26. PubMed ID: 12759248 [Abstract] [Full Text] [Related]
6. Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts. Harris SR, Schoeffner DJ, Yoshiji H, Thorgeirsson UP. Cancer Lett; 2002 May 08; 179(1):95-101. PubMed ID: 11880187 [Abstract] [Full Text] [Related]
7. Expression of type 2 nitric oxide synthase and vascular endothelial growth factor in oral dysplasia. Brennan PA, Umar T, Wilson AW, Mellor TK. J Oral Maxillofac Surg; 2002 Dec 08; 60(12):1455-60. PubMed ID: 12465010 [Abstract] [Full Text] [Related]
8. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Zhang L, Yu D, Hu M, Xiong S, Lang A, Ellis LM, Pollock RE. Cancer Res; 2000 Jul 01; 60(13):3655-61. PubMed ID: 10910082 [Abstract] [Full Text] [Related]
9. Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53. Cook T, Wang Z, Alber S, Liu K, Watkins SC, Vodovotz Y, Billiar TR, Blumberg D. Cancer Res; 2004 Nov 01; 64(21):8015-21. PubMed ID: 15520210 [Abstract] [Full Text] [Related]
10. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density. Fontanini G, Boldrini L, Calcinai A, Chinè S, Lucchi M, Mussi A, Angeletti CA, Basolo F, Bevilacqua G. Clin Cancer Res; 1999 Jan 01; 5(1):155-61. PubMed ID: 9918214 [Abstract] [Full Text] [Related]
11. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, Pairolero P, Trastek V, Jett J, Caporaso NE, Liotta LA, Harris CC. Clin Cancer Res; 2000 Dec 01; 6(12):4739-44. PubMed ID: 11156228 [Abstract] [Full Text] [Related]
16. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Zeng G, Gao L, Birklé S, Yu RK. Cancer Res; 2000 Dec 01; 60(23):6670-6. PubMed ID: 11118051 [Abstract] [Full Text] [Related]
17. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM. Cancer; 2000 Aug 01; 89(3):488-99. PubMed ID: 10931447 [Abstract] [Full Text] [Related]
18. RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. Claudio PP, Stiegler P, Howard CM, Bellan C, Minimo C, Tosi GM, Rak J, Kovatich A, De Fazio P, Micheli P, Caputi M, Leoncini L, Kerbel R, Giordano GG, Giordano A. Cancer Res; 2001 Jan 15; 61(2):462-8. PubMed ID: 11212232 [Abstract] [Full Text] [Related]
19. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer. Malone JM, Saed GM, Diamond MP, Sokol RJ, Munkarah AR. Am J Obstet Gynecol; 2006 Apr 15; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304 [Abstract] [Full Text] [Related]
20. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR. Cancer Res; 1999 Jul 15; 59(14):3374-8. PubMed ID: 10416597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]